ArticleBiomarker research2024

PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals.

Ji Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.